Blackstone Commits $455 Million to Co-Fund Boston Scientific’s Vitalyst Heart Pump
Blackstone Life Sciences will put up to $455 million behind Boston Scientific’s Vitalyst heart pump for cardiogenic shock, aiming toward a 2030 launch.
Medical devices